These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3702146)

  • 21. Brain monoamines in the rhesus monkey during long-term neuroleptic administration.
    Shannak KS; Hornykiewicz O
    Adv Biochem Psychopharmacol; 1980; 24():315-23. PubMed ID: 6157310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The attenuation effect of chlorpromazine on electro-acupuncture analgesia: involvement of dopamine system.
    Dai JL; Xu SF
    Acupunct Electrother Res; 1991; 16(3-4):101-9. PubMed ID: 1685618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of metoclopramide on the absorption and pharmacology of chlorpromazine in the rat.
    Imamura Y; Harada S; Okano Y; Miyata T; Otagiri M
    J Pharm Pharmacol; 1988 Feb; 40(2):116-9. PubMed ID: 2897442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chlorpromazine attenuated electroacupuncture analgesia in conscious rabbits.
    Dai JL; Xu SF
    Zhongguo Yao Li Xue Bao; 1993 Sep; 14(5):388-92. PubMed ID: 8010023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genotype-treatment interaction between amantadine and chlorpromazine in the mouse.
    Messiha FS
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1991; 99(3):323-6. PubMed ID: 1723037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regional effects of ceruletide, a cholecystokinin-8 analog, on the striatal monoaminergic systems in food-deprived mice.
    Yamada T; Kimura H
    Brain Res; 1991 Feb; 540(1-2):25-30. PubMed ID: 1711395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Tissue concentrations of biogenic amines in brain tumors and their distribution].
    Ikeda Y; Nakazawa S
    No Shinkei Geka; 1984 Jun; 12(7):787-93. PubMed ID: 6483088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of chlorpromazine and some of its metabolites on the EEG and on dopamine metabolism of the isolated perfused rat brain.
    Krieglstein J; Rieger H; Schütz H
    Eur J Pharmacol; 1979 Jul; 56(4):363-70. PubMed ID: 477730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simultaneous measurement of biogenic amines and related compounds by high performance liquid chromatography (HPLC).
    Shibuya T; Sato K; Salafsky B
    Int J Clin Pharmacol Ther Toxicol; 1982 Jul; 20(7):297-301. PubMed ID: 7107080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of CGP 11305 A, a new reversible and selective inhibitor of MAO A, on biogenic amine levels and metabolism in the rat brain.
    Waldmeier PC; Baumann PA
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Sep; 324(1):20-6. PubMed ID: 6195533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Naloxone-precipitated changes in biogenic amines and their metabolites in various brain regions of butorphanol-dependent rats.
    Tokuyama S; Wakabayashi H; Hoskins B; Ho IK
    Pharmacol Biochem Behav; 1996 Jun; 54(2):461-8. PubMed ID: 8743609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of neuroleptic-induced dopamine D2 receptor supersensitivity by chronic iron salt treatment.
    Ben-Shachar D; Pinhassi B; Youdim MB
    Eur J Pharmacol; 1991 Sep; 202(2):177-83. PubMed ID: 1687031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mouse strain-dependent effect of amantadine on motility and brain biogenic amines.
    Messiha FS
    Arch Int Pharmacodyn Ther; 1989; 302():74-85. PubMed ID: 2484011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-performance liquid chromatography of biogenic amines and metabolites in brain, cerebrospinal fluid, urine and plasma.
    Seegal RF; Brosch KO; Bush B
    J Chromatogr; 1986 Apr; 377():131-44. PubMed ID: 2423546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The effect of bromantane on the dopamin- and serotoninergic systems of the rat brain].
    Kudrin VS; Sergeeva SA; Krasnykh LM; Miroshnichenko II; Grekhova TV; Gaĭnetdinov RR
    Eksp Klin Farmakol; 1995; 58(4):8-11. PubMed ID: 7580761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-propargylbenzylamine, a major metabolite of pargyline, is a potent inhibitor of monoamine oxidase type B in rats in vivo: a comparison with deprenyl.
    Karoum F
    Br J Pharmacol; 1987 Feb; 90(2):335-45. PubMed ID: 3103805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of chlorpromazine on hypothalamic aminergic neurons and stress responses in moderate cold.
    Kortelainen ML; Lapinlampi T; Hirvonen J
    Eur J Appl Physiol Occup Physiol; 1989; 58(5):514-21. PubMed ID: 2759078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discrete regional distribution of biochemical markers for the dopamine, noradrenaline, serotonin, GABA and acetylcholine systems in the monkey brain (Cebus Apella). Effects of stress.
    Häggström JE; Sjöquist B; Eckernäs SA; Ingvast A; Gunne LM
    Acta Physiol Scand Suppl; 1984; 534():1-27. PubMed ID: 6150601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of serotonin receptors and lack of effect of antidepressant therapy on monoamine functions in various regions of the rabbit brain.
    Schoups A; Dillen L; Claeys M; Duchateau A; Verbeuren TJ; De Potter WP
    Eur J Pharmacol; 1986 Jul; 126(3):259-71. PubMed ID: 3758172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Formation of deaminated metabolites of dopamine in noradrenaline neurons.
    Andén NE; Grabowska-Andén M
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Sep; 324(1):1-6. PubMed ID: 6633676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.